SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004117
Filing Date
2021-11-10
Accepted
2021-11-10 16:31:26
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20210930.htm   iXBRL 10-Q 2743876
2 EX-31.1 vera-ex31_1.htm EX-31.1 17998
3 EX-31.2 vera-ex31_2.htm EX-31.2 17970
4 EX-32.1 vera-ex32_1.htm EX-32.1 11533
5 EX-32.2 vera-ex32_2.htm EX-32.2 11758
  Complete submission text file 0000950170-21-004117.txt   8590467

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vera-20210930_def.xml EX-101.DEF 265554
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20210930_lab.xml EX-101.LAB 434534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vera-20210930_cal.xml EX-101.CAL 36659
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20210930.xsd EX-101.SCH 59419
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20210930_pre.xml EX-101.PRE 347575
11 EXTRACTED XBRL INSTANCE DOCUMENT vera-20210930_htm.xml XML 1335355
Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 211397176
SIC: 2834 Pharmaceutical Preparations